Ranking by Regions
United States
Canada
Mexico
Brazil
Chile
Germany
United Kingdom
France
Spain
Netherlands
Sweden
Italy
Switzerland
Poland
Finland
China
Japan
South Korea
Hong Kong
Singapore
Indonesia
India
Malaysia
Taiwan
Thailand
Australia
New Zealand
Israel
Saudi Arabia
Turkey
Russia
South AfricaRanking by categories
As of April 19, 2025, VistaGen Therapeutics (VTGN) has a market cap of $60.899 million USD. According to our data, VistaGen Therapeutics is ranked No.7934 in global market value.
| Year | Market Cap | %Change |
|---|---|---|
| Apr 19, 2025 | $60.90 M |
-25.86%
|
| Dec 31, 2024 | $82.14 M |
-42.61%
|
| Dec 29, 2023 | $0.14 B |
71.33%
|
| Dec 30, 2022 | $83.53 M |
-94.87%
|
| Dec 31, 2021 | $1.63 B |
0.52%
|
| Dec 31, 2020 | $1.62 B |
181.16%
|
| Dec 31, 2019 | $0.58 B |
-54.00%
|
| Dec 31, 2018 | $1.25 B |
35.14%
|
| Dec 29, 2017 | $0.93 B |
-70.24%
|
| Dec 30, 2016 | $3.12 B |
-62.09%
|
| Dec 31, 2015 | $8.22 B |
15.76%
|
| Dec 31, 2014 | $7.10 B |
1.19%
|
| Dec 31, 2013 | $7.02 B |
-42.47%
|
| Dec 31, 2012 | $12.20 B |
-76.07%
|
| Dec 30, 2011 | $50.95 B |
100%
|
| Name | Market Cap | Market cap difference | Regions |
|---|---|---|---|
 Axsome Therapeutics
AXSM
|
$5.09 B |
-0.000 M
|
USA
|
 Sage Therapeutics
SAGE
|
$0.46 B |
-0.000 M
|
USA
|
 Intra-Cellular Therapies
ITCI
|
$14.05 B |
0.000 M
|
USA
|
 Alkermes
ALKS
|
$4.45 B |
-0.000 M
|
Ireland
|
 ACADIA Pharmaceuticals
ACAD
|
$2.46 B |
0.000 M
|
USA
|
 Biohaven Pharmaceutical
BHVN
|
$2.08 B |
0.000 M
|
USA
|
 Minerva Neurosciences
NERV
|
$11.19 M |
0.000 M
|
USA
|
 Marinus Pharmaceuticals
MRNS
|
$30.37 M |
0.028 M
|
USA
|
 Cassava Sciences
SAVA
|
$69.56 M |
-0.000 M
|
USA
|
 Corcept Therapeutics
CORT
|
$6.57 B |
0.000 M
|
USA
|
 Neurocrine Biosciences
NBIX
|
$10.03 B |
-0.000 M
|
USA
|
 Ovid Therapeutics
OVID
|
$20.51 M |
0.000 M
|
USA
|
 Relmada Therapeutics
RLMD
|
$9.62 M |
-0.007 M
|
USA
|
| Market Cap | = | VTGN Stock Price | * | VTGN Shares Outstanding |
| = | $2.11 | * | 28.86 M | |
| = | $60.90 M |